NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Languages English Remove constraint Languages: English

Search Results

8431. Osteoporosis: nonclinical evaluation of drugs intended for treatment

8432. Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products

8433. Factors to consider when making benefit-risk determinations in medical device premarket approval and de novo classifications: guidance for industry and Food and Drug Administration staff

8434. Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff

8435. Evaluation of internal standard responses during chromatographic bioanalysis: questions and answers

8436. Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older

8437. Humanitarian device exemption (HDE) program: guidance for industry and Food and Drug Administration staff

8439. Citizen petitions and petitions for stay of action subject to section 505(q) of the Federal Food, Drug, and Cosmetic Act

8440. Wholesale distributor verification requirement for saleable returned drug product: compliance policy